Functional studies of TP63-affected ESCC tumor immune microenvironment

Our preliminary data from unbiased analyses of both ESCC patient samples and cell lines identified interferon-? (IFN-?) signaling pathway as the most significantly enriched pathways suppressed by TP63. To validate the activation of IFN pathways and the immune responses upon silencing of TP63, we utilized immune-competent mice to conduct allograft experiments. To analyze the effect of TP63 on ESCC tumor microenvironment, resected tumors were then collected to perform scRNA-seq. Overall design: Excised tumors were dissociated into single cells and enriched with CD45 microbeads, then rendered to scRNA-seq.